ClearAlpha Technologies’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

ClearAlpha Technologies’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-40,539	Closed	-$5.35M	–	87
2025 Q1	$5.35M	Buy	40,539 +36,558	+918%	+$4.56M	3.38%	10
2024 Q4	$332K	Buy	+3,981	New	+$327K	0.23%	40

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ClearAlpha Technologies's ITCI Position: Q2 2025 in Review

ClearAlpha Technologies sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 40,539 shares — an estimated $5.35M sold.

ClearAlpha Technologies first reported a position in ITCI in Q4 2024 and held it in 2 quarters. The position peaked at $5.35M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

ClearAlpha Technologies reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
ClearAlpha Technologies sold 40,539 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $5.35M.
ClearAlpha Technologies first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 2 quarters.
ClearAlpha Technologies's Intra-Cellular Therapies Inc. position peaked at $5.35M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on ClearAlpha Technologies's 13F filing for Q2 2025, filed 14 Aug 2025.